US2015218264A1PendingUtilityA1
Methods for the humanization of antibodies and humanized antibodies thereby obtained
Est. expiryDec 24, 2023(expired)· nominal 20-yr term from priority
A61P 31/18A61P 35/00A61P 29/00A61P 25/04A61P 1/18A61P 13/08C07K 2299/00C07K 2317/76C07K 16/465C07K 2317/565C12N 15/85C07K 2317/24A61K 2039/505C07K 16/2863C07K 16/22G06F 19/16G16B 15/00
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method for the humanization of the VH and VL variable regions of an animal antibody of known sequence, humanized animal antibody obtainable according to the method, in particular anti-NGF and anti-TrkA humanized animal antibodies.
Claims
exact text as granted — not AI-modified1 . A method for humanizing the VH and VL variable regions of an anti-NGF antibody of non-human origin, comprising the steps of:
a) providing the crystallographic structure of the VH and VL regions of the anti-NGF antibody; b) pre-selecting a series of 0 to n possible frameworks acceptors of human origin or humanized antibodies, whose structure was determined experimentally with a resolution of no less than 3 Å, based on the highest level of homology and identity with the primary sequence of the framework of the anti-NGF antibody; c) conducting a structural comparison between the VH and VL variable regions of the anti-NGF antibody and the regions VH and VL obtained in b), respectively and calculating for each comparison the RMS, to identify the region VH and the region VL of human origin with the smaller RMS; and d) inserting in appropriate position the sequences of the regions CDR of the anti-NGF antibody in the human sequences identified in c).
2 - 24 . (canceled)Join the waitlist — get patent alerts
Track US2015218264A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.